Letters to the Editor

Red cell distribution width as a new prognostic biomarker in refractory chronic graft-versus-host disease

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD 20892
Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD 20892
Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892
Outcomes Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, 20850
Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD 20892
Haematologica Early view Aug 17, 2023 https://doi.org/10.3324/haematol.2023.283646